{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:20:01Z","timestamp":1791296401930,"version":"4.1.0"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"21","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Malignant melanoma continues to remain a significant health threat, with death often occurring as a result of metastasis. The metastatic phenotype typically is characterized by augmented tumor cell invasion and migration in addition to tumor cell plasticity as shown by vasculogenic mimicry. Therefore, understanding the molecular mechanisms that promote an aggressive phenotype is essential to predicting the likelihood of metastasis at a stage when intervention may be possible. This study focuses on the role of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase important for many cellular processes, including cell survival, invasion, and migration. We found FAK to be phosphorylated on its key tyrosine residues, Tyr397 and Tyr576, in only aggressive uveal and cutaneous melanoma cells, which correlates with their increased invasion, migration, and vasculogenic mimicry plasticity. Additionally, we confirmed the presence of FAK phosphorylated on Tyr397 and Tyr576 in both cutaneous and uveal melanoma tumors in situ. Examination of a functional role for FAK in aggressive melanoma revealed that disruption of FAK-mediated signal transduction pathways, through the expression of FAK-related nonkinase (FRNK), results in a decrease in melanoma cell invasion, migration, and inhibition of vasculogenic mimicry. Moreover, we found that FRNK expression resulted in a down-regulation of Erk1\/2 phosphorylation resulting in a decrease in urokinase activity. Collectively, these data suggest a new mechanism involved in promoting the aggressive melanoma phenotype through FAK-mediated signal transduction pathways, thus providing new insights into possible therapeutic intervention strategies.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-2172","type":"journal-article","created":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T20:38:54Z","timestamp":1130877534000},"page":"9851-9860","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Focal Adhesion Kinase Promotes the Aggressive Melanoma Phenotype"],"prefix":"10.1158","volume":"65","author":[{"given":"Angela R.","family":"Hess","sequence":"first","affiliation":[{"name":"1Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne-Marie","family":"Postovit","sequence":"additional","affiliation":[{"name":"1Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira V.","family":"Margaryan","sequence":"additional","affiliation":[{"name":"1Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"Seftor","sequence":"additional","affiliation":[{"name":"1Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galen B.","family":"Schneider","sequence":"additional","affiliation":[{"name":"3Dows Institute for Dental Research and Department of Prosthodontics, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.B.","family":"Seftor","sequence":"additional","affiliation":[{"name":"1Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Nickoloff","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Loyola University Medical Center, Chicago, Illinois; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.C.","family":"Hendrix","sequence":"additional","affiliation":[{"name":"1Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"2022061706304542800_B1","doi-asserted-by":"crossref","unstructured":"Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol\u20082000; 156: 361\u201381.","DOI":"10.1016\/S0002-9440(10)64739-6"},{"key":"2022061706304542800_B2","doi-asserted-by":"crossref","unstructured":"Bogenrieder T, Herlyn M. Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma. Crit Rev Oncol Hematol\u20082002; 44: 1\u201315.","DOI":"10.1016\/S1040-8428(01)00196-2"},{"key":"2022061706304542800_B3","doi-asserted-by":"crossref","unstructured":"Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol\u20081999; 71: 435\u201378.","DOI":"10.1016\/S0079-6107(98)00052-2"},{"key":"2022061706304542800_B4","doi-asserted-by":"crossref","unstructured":"Han NM, Fleming RY, Curley SA, Gallick GE. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann Surg Oncol\u20081997; 4: 264\u20138.","DOI":"10.1007\/BF02306620"},{"key":"2022061706304542800_B5","doi-asserted-by":"crossref","unstructured":"Maung K, Easty DJ, Hill SP, Bennett DC. Requirement for focal adhesion kinase in tumor cell adhesion. Oncogene\u20081999; 18: 6824\u20138.","DOI":"10.1038\/sj.onc.1203094"},{"key":"2022061706304542800_B6","doi-asserted-by":"crossref","unstructured":"Owens LV, Xu L, Dent GA, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol\u20081996; 3: 100\u20135.","DOI":"10.1007\/BF02409059"},{"key":"2022061706304542800_B7","doi-asserted-by":"crossref","unstructured":"Schneider GB, Kurago Z, Zaharias R, Gruman LM, Schaller MD, Hendrix MJ. Elevated focal adhesion kinase expression facilitates oral tumor cell invasion. Cancer\u20082002; 95: 2508\u201315.","DOI":"10.1002\/cncr.10992"},{"key":"2022061706304542800_B8","doi-asserted-by":"crossref","unstructured":"Sood AK, Coffin JE, Schneider GB, et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol\u20082004; 165: 1087\u201395.","DOI":"10.1016\/S0002-9440(10)63370-6"},{"key":"2022061706304542800_B9","doi-asserted-by":"crossref","unstructured":"Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapdelaine A, Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int J Cancer\u20081996; 68: 164\u201371.","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W"},{"key":"2022061706304542800_B10","doi-asserted-by":"crossref","unstructured":"Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer\u20082003; 3: 411\u201321.","DOI":"10.1038\/nrc1092"},{"key":"2022061706304542800_B11","unstructured":"Hendrix MJ, Seftor EA, Seftor RE, et al. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor\/scatter factor (HGF\/SF). Am J Pathol\u20081998; 152: 855\u201363."},{"key":"2022061706304542800_B12","doi-asserted-by":"crossref","unstructured":"Seftor EA, Meltzer PS, Kirschmann DA, et al. Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis\u20082002; 19: 233\u201346.","DOI":"10.1023\/A:1015591624171"},{"key":"2022061706304542800_B13","unstructured":"Hess AR, Seftor EA, Gardner LM, et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck\/EphA2). Cancer Res\u20082001; 61: 3250\u20135."},{"key":"2022061706304542800_B14","doi-asserted-by":"crossref","unstructured":"Yang GS, Schmidt M, Yan Z, et al. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol\u20082002; 76: 7651\u201360.","DOI":"10.1128\/JVI.76.15.7651-7660.2002"},{"key":"2022061706304542800_B15","doi-asserted-by":"crossref","unstructured":"Hendrix MJ, Seftor EA, Seftor RE, Fidler IJ. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett\u20081987; 38: 137\u201347.","DOI":"10.1016\/0304-3835(87)90209-6"},{"key":"2022061706304542800_B16","doi-asserted-by":"crossref","unstructured":"Postovit LM, Dutt P, Dourdin N, et al. Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cells. Biochem Biophys Res Commun\u20082002; 297: 294\u2013301.","DOI":"10.1016\/S0006-291X(02)02187-3"},{"key":"2022061706304542800_B17","unstructured":"Hess AR, Seftor EA, Seftor RE, Hendrix MJ. Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res\u20082003; 63: 4757\u201362."},{"key":"2022061706304542800_B18","doi-asserted-by":"crossref","unstructured":"Richardson A, Parsons T. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature\u20081996; 380: 538\u201340.","DOI":"10.1038\/380538a0"},{"key":"2022061706304542800_B19","doi-asserted-by":"crossref","unstructured":"Schaller MD, Borgman CA, Parsons JT. Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell Biol\u20081993; 13: 785\u201391.","DOI":"10.1128\/mcb.13.2.785-791.1993"},{"key":"2022061706304542800_B20","doi-asserted-by":"crossref","unstructured":"Ma Z, Webb DJ, Jo M, Gonias SL. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK\/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J Cell Sci\u20082001; 114: 3387\u201396.","DOI":"10.1242\/jcs.114.18.3387"},{"key":"2022061706304542800_B21","doi-asserted-by":"crossref","unstructured":"Nguyen DH, Webb DJ, Catling AD, et al. Urokinase-type plasminogen activator stimulates the Ras\/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2\/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem\u20082000; 275: 19382\u20138.","DOI":"10.1074\/jbc.M909575199"},{"key":"2022061706304542800_B22","doi-asserted-by":"crossref","unstructured":"Simon C, Hicks MJ, Nemechek AJ, et al. PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer\u20081999; 80: 1412\u20139.","DOI":"10.1038\/sj.bjc.6690537"},{"key":"2022061706304542800_B23","doi-asserted-by":"crossref","unstructured":"Kahana O, Micksche M, Witz IP, Yron I. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene\u20082002; 21: 3969\u201377.","DOI":"10.1038\/sj.onc.1205472"},{"key":"2022061706304542800_B24","unstructured":"Haskell H, Natarajan M, Hecker TP, et al. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin Cancer Res\u20082003; 9: 2157\u201365."},{"key":"2022061706304542800_B25","doi-asserted-by":"crossref","unstructured":"Aguirre Ghiso JA. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene\u20082002; 21: 2513\u201324.","DOI":"10.1038\/sj.onc.1205342"},{"key":"2022061706304542800_B26","unstructured":"Hauck CR, Sieg DJ, Hsia DA, et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res\u20082001; 61: 7079\u201390."},{"key":"2022061706304542800_B27","doi-asserted-by":"crossref","unstructured":"Hauck CR, Hsia DA, Puente XS, Cheresh DA, Schlaepfer DD. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J\u20082002; 21: 6289\u2013302.","DOI":"10.1093\/emboj\/cdf631"},{"key":"2022061706304542800_B28","unstructured":"Seftor RE, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 \u03b32 chain, matrix metalloproteinase-2, and membrane type-1-matrix\/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res\u20082001; 61: 6322\u20137."},{"key":"2022061706304542800_B29","doi-asserted-by":"crossref","unstructured":"Gray-Schopfer VC, da Rocha DS, Marais R. The role of B-RAF in melanoma. Cancer Metastasis Rev\u20082005; 24: 165\u201383.","DOI":"10.1007\/s10555-005-5865-1"},{"key":"2022061706304542800_B30","doi-asserted-by":"crossref","unstructured":"Sumimoto H, Miyagishi M, Miyoshi H, et al. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene\u20082004; 23: 6031\u20139.","DOI":"10.1038\/sj.onc.1207812"},{"key":"2022061706304542800_B31","doi-asserted-by":"crossref","unstructured":"Zuidervaart W, van NF, Stark M, et al. Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer\u20082005; 92: 2032\u20138.","DOI":"10.1038\/sj.bjc.6602598"},{"key":"2022061706304542800_B32","doi-asserted-by":"crossref","unstructured":"Akasaka T, van Leeuwen RL, Yoshinaga IG, Mihm MC, Jr., Byers HR. Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol\u20081995; 105: 104\u20138.","DOI":"10.1111\/1523-1747.ep12313396"},{"key":"2022061706304542800_B33","doi-asserted-by":"crossref","unstructured":"Li X, Regezi J, Ross FP, et al. Integrin \u03b1v\u03b23 mediates K1735 murine melanoma cell motility in vivo and in vitro. J Cell Sci\u20082001; 114: 2665\u201372.","DOI":"10.1242\/jcs.114.14.2665"},{"key":"2022061706304542800_B34","doi-asserted-by":"crossref","unstructured":"Seftor EA, Meltzer PS, Schatteman GC, et al. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol\u20082002; 44: 17\u201327.","DOI":"10.1016\/S1040-8428(01)00199-8"},{"key":"2022061706304542800_B35","doi-asserted-by":"crossref","unstructured":"Hendrix MJ, Seftor EA, Chu YW, et al. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential. J Natl Cancer Inst\u20081992; 84: 165\u201374.","DOI":"10.1093\/jnci\/84.3.165"},{"key":"2022061706304542800_B36","unstructured":"Juhasz I, Albelda SM, Elder DE, et al. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol\u20081993; 143: 528\u201337."},{"key":"2022061706304542800_B37","unstructured":"Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res\u20082001; 61: 3819\u201325."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/21\/9851\/2866428\/9851-9860.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/21\/9851\/2866428\/9851-9860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:11:47Z","timestamp":1655478707000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/21\/9851\/657459\/Focal-Adhesion-Kinase-Promotes-the-Aggressive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":37,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2005,11,1]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-2172","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22367805","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367814.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367808","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367808.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367802.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367805.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367811.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367811","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367814","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367802","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495696.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495696","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}